
Bio-Techne Corporation TECH
$ 64.72
-1.15%
Quarterly report 2025-Q4
added 02-04-2026
Bio-Techne Corporation DPO Ratio 2011-2026 | TECH
Annual DPO Ratio Bio-Techne Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26.9 | 29.8 | 29.6 | 33.1 | 32.1 | 28.1 | 24.6 | 31.9 | 32.6 | 46.4 | 33.8 | 33.1 | 28.6 | 29.2 | 29.2 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 46.4 | 24.6 | 31.3 |
Quarterly DPO Ratio Bio-Techne Corporation
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.6 | 25.7 | - | 29.1 | 28.6 | 29.8 | - | 27.9 | 28.3 | 26.7 | - | 25.4 | 28.2 | 32.6 | 16.6 | 29.6 | 27.9 | 28.9 | 15.6 | 32.5 | 32 | 34.5 | 28.7 | 28.9 | 23.8 | 21.3 | 23.3 | 22.7 | 25.4 | 30.2 | 27.4 | 24.5 | 23 | 31.2 | 29.4 | 29.1 | 28.3 | 36.8 | 40.3 | 30.8 | 27.4 | 32.8 | 31.2 | 32.8 | 33.6 | 29.9 | 24.3 | 21.7 | 24.8 | 24 | 22.4 | 23.6 | 29.9 | 30.1 | 29 | 28.6 | 27.3 | 26 | 24.4 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 40.3 | 15.6 | 27.7 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Amarin Corporation plc
AMRN
|
190 | $ 15.08 | 2.24 % | $ 6.15 B | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Aptorum Group Limited
APM
|
405 | $ 0.84 | 2.78 % | $ 4.58 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
AgeX Therapeutics
AGE
|
9.04 K | - | -10.17 % | $ 12.2 K | ||
|
Amneal Pharmaceuticals
AMRX
|
21.1 | $ 14.79 | 1.83 % | $ 4.57 B | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Codexis
CDXS
|
98.4 | $ 1.26 | -1.94 % | $ 92.5 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.33 | 1.75 % | $ 14.6 M |